Group One Trading, L.P. Vanda Pharmaceuticals Inc. Transaction History

Group One Trading, L.P.

$2.81 Billion
Q3 2025

A detailed history of Group One Trading, L.P. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 7,780 shares of VNDA stock, worth $33,843. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,780

Previous 555 1301.8%

Holding current value

$33,843

Previous $2,000 1800.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$4.19 - $5.1 $30,272 - $36,847	7,225 Added 1301.8%	7,780 $38,000
Q2 2025 Aug 13, 2025	BUY	$3.92 - $4.82 $2,175 - $2,675	555 New	555 $2,000
Q1 2025 May 14, 2025	SELL	$4.31 - $5.13 $3,697 - $4,401	-858 Closed	0 $0
Q4 2024 Feb 14, 2025	BUY	$4.41 - $5.46 $3,783 - $4,684	858 New	858 $4,000
Q2 2024 Aug 14, 2024	BUY	$3.91 - $6.5 $260,937 - $433,784	66,736 Added 242.5%	94,256 $532,000

Q1 2024 May 10, 2024	BUY	$3.47 - $4.61 $86,618 - $115,074	24,962 Added 975.84%	27,520 $113,000
Q4 2023 Feb 14, 2024	BUY	$3.38 - $4.58 $1,875 - $2,541	555 Added 27.71%	2,558 $10,000
Q3 2023 Nov 09, 2023	BUY	$4.28 - $6.57 $8,144 - $12,502	1,903 Added 1903.0%	2,003 $8,000
Q1 2023 May 12, 2023	BUY	$6.18 - $7.99 $618 - $799	100 New	100 $0
Q2 2022 Aug 11, 2022	SELL	$9.31 - $11.84 $15,119 - $19,228	-1,624 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$10.84 - $16.55 $132,855 - $202,836	-12,256 Reduced 88.3%	1,624 $18,000
Q4 2021 Feb 11, 2022	BUY	$15.69 - $21.14 $188,860 - $254,462	12,037 Added 653.12%	13,880 $218,000
Q3 2021 Nov 12, 2021	SELL	$15.35 - $21.27 $158,473 - $219,591	-10,324 Reduced 84.85%	1,843 $32,000
Q2 2021 Aug 10, 2021	BUY	$15.71 - $21.51 $181,152 - $248,031	11,531 Added 1813.05%	12,167 $262,000
Q1 2021 May 12, 2021	SELL	$13.42 - $20.28 $38,730 - $58,528	-2,886 Reduced 81.94%	636 $10,000
Q4 2020 Feb 10, 2021	SELL	$9.77 - $13.81 $18,387 - $25,990	-1,882 Reduced 34.83%	3,522 $46,000
Q3 2020 Nov 12, 2020	BUY	$9.32 - $12.02 $49,396 - $63,706	5,300 Added 5096.15%	5,404 $52,000
Q2 2020 Aug 13, 2020	BUY	$9.66 - $12.02 $1,004 - $1,250	104 New	104 $1,000
Q1 2020 May 13, 2020	SELL	$7.5 - $16.8 $5,550 - $12,432	-740 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$12.38 - $17.47 $1,485 - $2,096	120 Added 19.35%	740 $12,000
Q3 2019 Nov 12, 2019	BUY	$12.27 - $15.79 $7,607 - $9,789	620 New	620 $8,000
Q4 2018 Feb 06, 2019	SELL	$18.97 - $31.47 $139,069 - $230,706	-7,331 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$18.25 - $23.0 $133,790 - $168,613	7,331 New	7,331 $168,000
Q1 2018 May 11, 2018	SELL	$14.05 - $20.2 $34,577 - $49,712	-2,461 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$12.85 - $18.1 $31,623 - $44,544	2,461	2,461 $37,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.5M

Call Options Held

159K

Put Options Held

229K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $246M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Vanda Pharmaceuticals Inc. Transaction History